Global Health (MEDANTA) Share Price Falls 2.27%: What MEDANTA Share Price Shows

Global Health Share Price moved lower today, with MEDANTA trading at Rs 1,248.55, down 2.27% from the previous close, and the company’s market capitalisation stood at Rs 34,406.56 crore. The stock opened at Rs 1,267, touched a high of Rs 1,277.10 and a low of Rs 1,245.75, placing the move squarely within the day’s range as of 16 October 2026 at 1:04:35 PM IST. For readers tracking Global Health Share Price Today, the key point is simple: this is a price fall in a Large Cap healthcare name, not a broad statement about the company’s business quality. The price move is confirmed in Univest data; a company-specific reason has not been established. That makes the move relevant for Global Health Stock News, Global Health Share Price News and deeper Global Health Fundamental Analysis.

Global Health (MEDANTA) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,248.55
Previous Close	Rs 1,277.55
Today's Move	-Rs 29.00 (-2.27%)
Open	Rs 1,267
High	Rs 1,277.1
Low	Rs 1,245.75
Market Capitalisation	Rs 34,406.56 crore
Market Cap Category	Large Cap

Global Health Share Price Today reflects a Rs 29 decline from the previous close of Rs 1,277.55, with the stock last traded at Rs 1,248.55. The opening price of Rs 1,267 stayed below the prior close, while the day’s high of Rs 1,277.10 came close to the previous close and the day’s low of Rs 1,245.75 marked the weakest point in the range. For a Large Cap stock, that range matters because it shows where price discovery stood during the trading window. Global Health Share Price therefore moved from an early level near the prior close to a lower last traded level by 1:04:35 PM IST. The market capitalisation of Rs 34,406.56 crore keeps MEDANTA firmly in the Large Cap bracket, which is useful context for Global Health Share Price fall narratives and Global Health Stock Performance monitoring.

For Univest readers following Global Health Share Price Live, the movement is best read as a one-day decline with a defined opening, high and low, not as a longer trend statement. The price action now leads naturally into Global Health Fundamental Analysis.

Global Health (MEDANTA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 34,406.56 crore
P/E Ratio	61.76x
P/B Ratio	8.35x
ROE	15.12%
ROCE	19.38%
EPS	Rs 20.69
Book Value Per Share	Rs 152.94
Dividend Yield	0.04%

Global Health (MEDANTA) fundamental metrics show P/E 61.76x, P/B 8.35x, ROE 15.12%, ROCE 19.38%. These ratios show where the company stands today and are not a call to buy or sell.

Global Health has a market capitalisation of Rs 34,406.56 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 61.76x, P/B at 8.35x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 15.12% and ROCE of 19.38%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 20.69, book value per share of Rs 152.94, dividend yield of 0.04%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 42.67x, median ROE of 12.95%, median ROCE of 15.83%. Together they describe the fundamental backdrop without implying a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Hospital & Healthcare Services
Benchmark Scope	same industry
Company P/E Ratio	61.76x
Benchmark Median P/E	42.67x
Benchmark Average P/E	93.45x
Benchmark P/E Range	7.02x to 1,517.44x
Company P/B Ratio	8.35x
Benchmark Median P/B	3.65x
Benchmark Average P/B	4.04x
Company ROE	15.12%
Benchmark Median ROE	12.95%
Benchmark Average ROE	11.24%
Company ROCE	19.38%
Benchmark Median ROCE	15.83%
Benchmark Average ROCE	2.2%
Company Market Capitalisation	Rs 34,406.56 crore
Benchmark Median Market Cap	Rs 530.59 crore
Benchmark Average Market Cap	Rs 10,054.72 crore

Global Health (MEDANTA) operates in the Healthcare sector, within the Hospital & Healthcare Services industry.

Global Health (MEDANTA) has a P/E ratio of 61.76x, which is above the benchmark median of 42.67x, a difference of +44.74%. A P/E difference of this kind is a reference point rather than a recommendation.

Global Health (MEDANTA) has a ROE of 15.12%, which is above the benchmark median of 12.95%, a difference of +16.76%. Global Health (MEDANTA) has a ROCE of 19.38%, which is above the benchmark median of 15.83%, a difference of +22.43%.

Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Apollo Hospitals Enterprise	APOLLOHOSP	1,12,295.82	54.61	11.78	23.54	21.73
MANIPAL HEALTH ENTERPRI L	MANIPALHOS	85,492.94	94.59	5.09	12.95	13.93
Max Healthcare Institute	MAXHEALTH	83,023.36	57.25	7.63	14.53	14.97
Aster DM Healthcare	ASTERDM	58,872.76	186.6	14.06	13.07	16.22
Fortis Healthcare	FORTIS	56,576.56	53.5	5.52	11.32	14.07

Global Health (MEDANTA) has a P/E ratio of 61.76x compared with the displayed peer median of 57.25x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 15.12% compares with a peer median of 13.07% across the companies shown in the table. ROCE stood at 19.38% versus the displayed peer median of 14.97%, providing a capital-efficiency comparison. Global Health (MEDANTA) has a market capitalisation of Rs 34,406.56 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Global Health

• Global Health Share Price fell 2.27% today, giving MEDANTA a clear intraday price event to track.
• The stock traded between Rs 1,245.75 and Rs 1,277.10, with the last traded price at Rs 1,248.55.
• Global Health Share Price remains a Large Cap with Rs 34,406.56 crore market capitalisation.
• Valuation stays elevated at a P/E of 61.76 and P/B of 8.35, which matters for Global Health Fundamental Analysis.
• ROE of 15.12% and ROCE of 19.38% provide context for the premium valuation in the healthcare sector.

About Global Health

Global Health operates in the Healthcare sector and the Hospital & Healthcare Services industry. The business is known through MEDANTA and sits among India’s larger listed healthcare names. For Global Health Share Price readers, the company context matters because the stock is priced as a Large Cap healthcare platform rather than a small specialty play. Its market profile is shaped by hospital and related healthcare services, and its current valuation shows how the market views that operating model relative to peers. Global Health Stock News typically reflects both price action and the broader operating backdrop, which is why Univest tracks the name through market cap, ratios and peer comparisons.

Track Global Health Share Price on Univest

Use Global Health (MEDANTA) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.

Univest lets readers follow Global Health Share Price Live, key valuation ratios, 52-week levels and market insights in one place. For MEDANTA, that means you can review Global Health Share Price Today alongside peer context, market capitalisation and the latest healthcare sector view. It is a practical way to keep Global Health Stock Analysis connected to the numbers that matter.

Frequently Asked Questions

Why is Global Health Share Price falling today?

Ans. Global Health Share Price fell 2.27% to Rs 1,248.55. The price move is confirmed in Univest data; a company-specific reason has not been established. The move should be read through the day’s price action and valuation context.

What is Global Health Share Price Today?

Ans. Global Health Share Price Today is Rs 1,248.55, which is Rs 29 below the previous close of Rs 1,277.55. The stock traded between Rs 1,245.75 and Rs 1,277.10 during the current market window.

How much did MEDANTA decline in the latest trade?

Ans. MEDANTA declined Rs 29, or 2.27%, from the previous close. The fall placed Global Health Share Price below the opening price of Rs 1,267 and near the day’s low of Rs 1,245.75.

What is the market capitalisation of Global Health ?

Ans. Global Health has a market capitalisation of Rs 34,406.56 crore. That keeps Global Health Share Price in the Large Cap category and well above the median company size in the same industry benchmark.

How does Global Health Share Price compare with healthcare peers?

Ans. Global Health Share Price trades at a P/E of 61.76, above Fortis and Max Healthcare, but below Manipal and Aster. Its market cap is close to Narayana Hrudayalaya and below Apollo, Max and Fortis’ larger peers.

Is Global Health expensive on valuation?

Ans. Global Health Share Price carries a P/E of 61.76 and a P/B of 8.35, both above the industry median. Those levels place the stock on the richer side of healthcare valuations, especially versus the peer benchmark median.

What do ROE and ROCE show for Global Health ?

Ans. Global Health reports ROE of 15.12% and ROCE of 19.38%. For Global Health Share Price analysis, these return ratios are above the benchmark median, which helps explain the premium valuation structure.

What are the key numbers behind Global Health Fundamental Analysis?

Ans. Global Health Fundamental Analysis includes P/E of 61.76, P/B of 8.35, EPS of Rs 20.69, book value of Rs 152.94 and dividend yield of 0.04%. These figures frame the stock’s premium healthcare profile.

Should investors track Global Health Share Price on Univest?

Ans. Yes, because Univest shows Global Health Share Price alongside valuation ratios, 52-week levels, market capitalisation and peer context. That makes it easier to follow MEDANTA’s price action and sector positioning in one place.